SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Pursuant to regulation 30 of the SEBI (Listing Obligation & Disclosure Requirements) Regulations, 2015, we enclose herewith the Press Release on the above mentioned subject being released by the Company, which is self-explanatory. We request you to kindly take the same on record. SPARC slips 10% as USFDA rejects cancer drug application
The company has received a Complete Response Letter (CRL) from the USFDA for the new drug application (NDA) for Taclantis (Paclitaxel Injection Concentrate for Suspension). Sun Pharma Advanced Research Company Ltd - 532872 - Update On TACLANTIS(tm) (Paclitaxel Injection Concentrate For Suspension) NDA
Pursuant to regulation 30 of the SEBI (Listing Obligation & Disclosure Requirements) Regulations, 2015, we inform you that the Company has received a Complete Response Letter (CRL) from the United States Food & Drug Administration (USFDA) for the New Drug Application (NDA) for Taclantis(tm) (Paclitaxel Injection Concentrate for Suspension). Company is reviewing the CRL and intends to work with the USFDA as soon as possible to address the concerns raised. SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to regulation 39(3) of the SEBI (Listing Obligation & Disclosure Requirements) Regulations, 2015, we hereby inform you that the share certificate as per attached details, issued by the Company, have been reported by the registered shareholder(s)/ bona fide purchasers to have been lost/ misplaced/stolen. Sun Pharma Advanced Research Company Ltd - 532872 - Loss of Share Certificate / Issue of Duplicate Share Certificate
Loss of Share Certificate / Issue of Duplicate Share Certificate. SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Results For The Quarter Ended 31St December 2019
The Board of Directors of the Company at their meeting held from 07:30 pm to 09:00 pm today, inter alia, took on record and duly approved the Un-audited financial results of the Company for the quarter ended 31st December 2020 which is enclosed herewith along with the Limited Review Report of the Auditors thereon as Annexure I. This is for your information and record. Sun Pharma Advanced Research Company Ltd - 532872 - Board Meeting Intimation for Notice Of Board Meeting For Consideration Of Unaudited Financial Results Of The Company For The Quarter And Nine Months Ended 31St December 2019.
SUN PHARMA ADVANCED RESEARCH COMPANY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/01/2020 ,inter alia, to consider and approve Pursuant to regulation 29 (1) of the SEBI (Listing obligation & Disclosure Requirements) Regulation, 2015, we hereby inform you that a meeting of the Board of Directors of Sun Pharma Advanced Research Company Limited will be held on Friday, 31st January 2020, inter alia, to consider and take on record, the unaudited financial results of the Company for the quarter and nine months ended 31st December 2019. Sun Pharma Advanced Research Company Ltd - 532872 - Shareholding for the Period Ended December 31, 2019
Sun Pharma Advanced Research Company Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2019. For more details, kindly Click here SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Statement Of Investor Complaints For The Quarter Ended December 2019
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- DEBASHIS DEYDesignation :- Company Secretary and Compliance Officer Sun Pharma Advanced Research Company Ltd - 532872 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to regulation 39(3) of the SEBI (Listing Obligation & Disclosure Requirements) Regulations, 2015, we hereby inform you that the share certificate(s) as per attached details, issued by the Company, have been reported by the registered shareholder(s)/ bona fide purchasers to have been lost/ misplaced/stolen.